[HTML][HTML] Designing a VAR2CSA-based vaccine to prevent placental malaria

M Fried, PE Duffy - Vaccine, 2015 - Elsevier
Placental malaria (PM) due to Plasmodium falciparum is a major cause of maternal, fetal
and infant mortality, but the mechanisms of pathogenesis and protective immunity are …

[HTML][HTML] Progress and insights toward an effective placental malaria vaccine

B Gamain, A Chêne, NK Viebig… - Frontiers in …, 2021 - frontiersin.org
In areas where Plasmodium falciparum transmission is endemic, clinical immunity against
malaria is progressively acquired during childhood and adults are usually protected against …

[HTML][HTML] The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains

M Dahlbäck, LM Jørgensen, MA Nielsen… - Journal of Biological …, 2011 - ASBMB
Malaria during pregnancy is a major health problem for African women. The disease is
caused by Plasmodium falciparum malaria parasites, which accumulate in the placenta by …

[HTML][HTML] Cytoadherence and severe malaria

GC Alister, KMF Mustaffa… - The Malaysian journal of …, 2012 - ncbi.nlm.nih.gov
Malaria is a disease that causes enormous human morbidity and mortality. One feature of
mature Plasmodium falciparum-infected erythrocytes leading to the development of severe …

[HTML][HTML] Var2CSA minimal CSA binding region is located within the N-terminal region

A Srivastava, S Gangnard, S Dechavanne, F Amirat… - PloS one, 2011 - journals.plos.org
Var2CSA, a key molecule linked with pregnancy-associated malaria (PAM), causes
sequestration of Plasmodium falciparum infected erythrocytes (PEs) in the placenta by …

[HTML][HTML] Plasmodium falciparum Expressing Domain Cassette 5 Type PfEMP1 (DC5-PfEMP1) Bind PECAM1

SS Berger, L Turner, CW Wang, JEV Petersen, M Kraft… - PloS one, 2013 - journals.plos.org
Members of the Plasmodium falciparum Erythrocyte Membrane protein 1 (PfEMP1) family
expressed on the surface of malaria-infected erythrocytes mediate binding of the parasite to …

[HTML][HTML] The influence of sub-unit composition and expression system on the functional antibody response in the development of a VAR2CSA based Plasmodium …

MA Nielsen, M Resende, WA de Jongh, SB Ditlev… - PLoS …, 2015 - journals.plos.org
The disease caused by Plasmodium falciparum (Pf) involves different clinical manifestations
that, cumulatively, kill hundreds of thousands every year. Placental malaria (PM) is one such …

[HTML][HTML] Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade

JC Patel, NJ Hathaway, CM Parobek, KL Thwai… - Scientific reports, 2017 - nature.com
Pregnancy associated malaria (PAM) causes adverse pregnancy and birth outcomes owing
to Plasmodium falciparum accumulation in the placenta. Placental accumulation is mediated …

[HTML][HTML] Immunisation with Recombinant PfEMP1 Domains Elicits Functional Rosette-Inhibiting and Phagocytosis-Inducing Antibodies to Plasmodium falciparum

A Ghumra, P Khunrae, R Ataide, A Raza, SJ Rogerson… - PloS one, 2011 - journals.plos.org
Background Rosetting is a Plasmodium falciparum virulence factor implicated in the
pathogenesis of life-threatening malaria. Rosetting occurs when parasite–derived P …

VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria

JYA Doritchamou, R Herrera, JA Aebig… - The Journal of …, 2016 - academic.oup.com
Background. Placental malaria is caused by Plasmodium falciparum–infected erythrocytes
(IEs) that surface-express VAR2CSA and bind chondroitin sulfate A. The inflammatory …